Disclaimer: For the use of registered Medical practitioner or research lab
The Virulina formulation has been formulated after extensive literature survey on the Indian medicinal plants and their reported traditional use and applications in reference to Aurvedic text books and formularies, and also based on past experimental data reported on pharmacological activities relevant to antiviral and immunomodulator activities. Thus the selection of the medicinal plants, their parts or extracts is based on evidences reported through the data.
Virulina is a research product by Dr Anil Sharma (Clinician & Researcher ) & Dr. Sandeep Arora (Professor & Director, Amity Institute of Pharmacy) for which patent has been granted bearing IPR No:404858
Anti-viral study was conducted at
Regional Centre for Biotechnology
( 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad Rd, Faridabad, Haryana 121001)
Virulina exhbit 95.9% inhibition activity visa vis 98.6% of remdesiver
on Corona Virus(Wuhan Strain)
In Vitro Study was conducted at
(Chitkara Universtiy, Chandigarh-Patiala National Highway (NH- 64 Village Jansla, Rajpura, Punjab)
In vitro studies states that Virulina® Proliferates T-Lymphocyte which triggers antibody producing T-Cell, Beta cells and Antigen cells.
Clinical trials were conducted at
(Government Medical College & Government General Hospital, Hudco Colony, Balaga, Srikakulam, A. P. 532001)
A double blind, placebo controlled, randomized clinical trial to evaluate the efficacy and safety of the Virulina®
* For any further information please write to us on email: info@virulina.com